Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pfister

Showing results (611-620 of 666) with videos related to

Pageof 67
Sort By:
Cancer Cell|May 13, 2015
Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age GroupsKristian W Pajtler, Hendrik Witt, Martin Sill, et al.
Acta Neuropathologica|August 6, 2021
Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumorsPhilipp Sievers, Sophie C Henneken, Christina Blume, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2021
Integrated Molecular-Morphologic Meningioma Classification: A Multicenter Retrospective Analysis, Retrospectively and Prospectively ValidatedSybren L N Maas, Damian Stichel, Thomas Hielscher, et al.
Cancer Research|November 3, 2017
PDX-MI: Minimal Information for Patient-Derived Tumor Xenograft ModelsTerrence F Meehan, Nathalie Conte, Theodore Goldstein, et al.
Acta Neuropathologica|August 21, 2021
PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrumKaram T Alhalabi, Damian Stichel, Philipp Sievers, et al.
Nature Medicine|March 17, 2023
Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncologyDominik Sturm, David Capper, Felipe Andreiuolo, et al.
Nature|January 31, 2012
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastomaJeremy Schwartzentruber, Andrey Korshunov, Xiao-Yang Liu, et al.
Neuro-Oncology|June 2, 2021
Therapeutic implications of improved molecular diagnostics for rare CNS embryonal tumor entities: results of an international, retrospective studyKatja von Hoff, Christine Haberler, Felix Schmitt-Hoffner, et al.
Pediatric Blood & Cancer|March 17, 2026
The HIT Network for Children and Adolescents With CNS Tumors Facilitates Improvements of Diagnostic Assessments, Multimodal Treatments, Individual Counseling, and Research in Germany, Austria, and SwitzerlandStefan Rutkowski, Michael C Frühwald, Gudrun Fleischhack, et al.
Acta Neuropathologica|July 19, 2018
Heterogeneity within the PF-EPN-B ependymoma subgroupFlorence M G Cavalli, Jens-Martin Hübner, Tanvi Sharma, et al.
Pageof 67

Showing results (611-620 of 666) with videos related to

Sort By:
Pageof 67
Cancer Cell|May 13, 2015
Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age GroupsKristian W Pajtler, Hendrik Witt, Martin Sill, et al.
Acta Neuropathologica|August 6, 2021
Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumorsPhilipp Sievers, Sophie C Henneken, Christina Blume, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2021
Integrated Molecular-Morphologic Meningioma Classification: A Multicenter Retrospective Analysis, Retrospectively and Prospectively ValidatedSybren L N Maas, Damian Stichel, Thomas Hielscher, et al.
Cancer Research|November 3, 2017
PDX-MI: Minimal Information for Patient-Derived Tumor Xenograft ModelsTerrence F Meehan, Nathalie Conte, Theodore Goldstein, et al.
Acta Neuropathologica|August 21, 2021
PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrumKaram T Alhalabi, Damian Stichel, Philipp Sievers, et al.
Nature Medicine|March 17, 2023
Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncologyDominik Sturm, David Capper, Felipe Andreiuolo, et al.
Nature|January 31, 2012
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastomaJeremy Schwartzentruber, Andrey Korshunov, Xiao-Yang Liu, et al.
Neuro-Oncology|June 2, 2021
Therapeutic implications of improved molecular diagnostics for rare CNS embryonal tumor entities: results of an international, retrospective studyKatja von Hoff, Christine Haberler, Felix Schmitt-Hoffner, et al.
Pediatric Blood & Cancer|March 17, 2026
The HIT Network for Children and Adolescents With CNS Tumors Facilitates Improvements of Diagnostic Assessments, Multimodal Treatments, Individual Counseling, and Research in Germany, Austria, and SwitzerlandStefan Rutkowski, Michael C Frühwald, Gudrun Fleischhack, et al.
Acta Neuropathologica|July 19, 2018
Heterogeneity within the PF-EPN-B ependymoma subgroupFlorence M G Cavalli, Jens-Martin Hübner, Tanvi Sharma, et al.
Pageof 67